Yield10 Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, revenue was USD 0.06 million compared to USD 0.252 million a year ago. Net loss was USD 7.46 million compared to USD 6.77 million a year ago. Basic loss per share from continuing operations was USD 33.36 compared to USD 33.12 a year ago. Diluted loss per share from continuing operations was USD 33.36 compared to USD 33.12 a year ago.